— Know what they know.
Not Investment Advice

APLIF Earnings

Appili Therapeutics Inc
1W: -22.2% 1M: +0.0% 3M: -34.5% YTD: -53.3% 1Y: -50.0% 3Y: -82.5% 5Y: -98.8%
$0.01
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Sell · Power 42 · $926563 mcap · 98M float · 0.021% daily turnover · Short 53% of daily vol
Last Earnings 2026-08-14
EPS
C$-0.01 (US$-0.01)
▲ Beat +75.1%
Revenue
C$83K ($58K)
▲ Beat +0.0%
Next Earnings 2026-11-12
EPS Estimate
C$-0.08 (US$-0.05)
Range: C$-0.08 - C$-0.08
Revenue Estimate
C$123K ($86K)
1 analysts
1 USD = 1.43 CAD

Estimate vs Actual

Earnings Surprise History

3/18
EPS Beats
0/18
Revenue Beats
17%
EPS Beat Rate
0%
Rev Beat Rate

Wall Street Forward Estimates

Quarterly
Annual

Estimate Revisions

Recent Revisions
DatePeriodFiscal DateEPS OldEPS NewChangeRev OldRev New
2026-10-02 quarter 2029-03-30 C$-0.02 C$-0.02 — C$149,644 C$149,644
2026-10-02 quarter 2026-09-30 C$-0.06 C$-0.06 — C$120,524 C$120,524
2026-10-02 quarter 2028-06-30 C$-0.03 C$-0.03 — C$140,238 C$140,238
2026-10-02 quarter 2029-06-30 C$-0.01 C$-0.01 — C$152,918 C$152,918
2026-10-02 quarter 2026-12-30 C$-0.08 C$-0.08 — C$123,161 C$123,161
2026-10-02 quarter 2027-12-30 C$-0.03 C$-0.03 — C$134,297 C$134,297
2026-10-02 quarter 2027-06-30 C$-0.10 C$-0.10 — C$128,608 C$128,608
2026-10-02 quarter 2028-09-30 C$-0.02 C$-0.02 — C$143,306 C$143,306
2026-10-02 quarter 2029-09-30 C$-0.01 C$-0.01 — C$156,264 C$156,264
2026-10-02 quarter 2028-12-30 C$-0.03 C$-0.03 — C$146,441 C$146,441
2026-10-02 quarter 2027-09-30 C$-0.11 C$-0.11 — C$131,422 C$131,422
2026-10-02 quarter 2028-03-30 C$-0.03 C$-0.03 — C$137,235 C$137,235
2026-10-02 quarter 2027-03-30 C$-0.09 C$-0.09 — C$125,855 C$125,855
2026-10-01 quarter 2028-12-30 C$-0.03 C$-0.03 — C$146,441 C$146,441
2026-10-01 quarter 2027-09-30 C$-0.11 C$-0.11 — C$131,422 C$131,422
Earnings Call Transcripts
No transcripts available.

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms